sharon sanders
Editor-in-Chief & President
http://wwwnc.cdc.gov/eid/article/21/1/14-1006_article
Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
On This Page
Margaret Okomo-Adhiambo, Alicia M. Fry, Su Su, Ha T. Nguyen, Anwar Abd Elal, Elizabeth Negron, Julie Hand, Rebecca J. Garten, John Barnes, Xu Xiyan, Julie M. Villanueva, Larisa V. Gubareva
, and 2013–14 US Influenza Antiviral Working Group
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Okomo-Adhiambo, A.M. Fry, S. Su, H.T. Nguyen, A.A Elal, R.J. Garten, J. Barnes, X. Xiyan, J.M Villanueva, L.V. Gubareva); Atlanta Research and Education Foundation, Atlanta (S. Su); Battelle Memorial Institute, Atlanta (H.T. Nguyen, A.A. Elal);Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA (E. Negron); Louisiana Office of Public Health, New Orleans, Louisiana, USA (J. Hand)
Suggested citation for this article
Abstract
We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infected with these viruses in the United States. During 2013–14, fifty-nine (1.2%) of 4,968 analyzed US influenza A(H1N1)pdm09 viruses had the H275Y oseltamivir resistance–conferring neuraminidase substitution. Our results emphasize the need for local surveillance for neuraminidase inhibitor susceptibility among circulating influenza viruses.
Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
On This Page
Margaret Okomo-Adhiambo, Alicia M. Fry, Su Su, Ha T. Nguyen, Anwar Abd Elal, Elizabeth Negron, Julie Hand, Rebecca J. Garten, John Barnes, Xu Xiyan, Julie M. Villanueva, Larisa V. Gubareva
, and 2013–14 US Influenza Antiviral Working GroupAuthor affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Okomo-Adhiambo, A.M. Fry, S. Su, H.T. Nguyen, A.A Elal, R.J. Garten, J. Barnes, X. Xiyan, J.M Villanueva, L.V. Gubareva); Atlanta Research and Education Foundation, Atlanta (S. Su); Battelle Memorial Institute, Atlanta (H.T. Nguyen, A.A. Elal);Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA (E. Negron); Louisiana Office of Public Health, New Orleans, Louisiana, USA (J. Hand)
Suggested citation for this article
Abstract
We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infected with these viruses in the United States. During 2013–14, fifty-nine (1.2%) of 4,968 analyzed US influenza A(H1N1)pdm09 viruses had the H275Y oseltamivir resistance–conferring neuraminidase substitution. Our results emphasize the need for local surveillance for neuraminidase inhibitor susceptibility among circulating influenza viruses.